Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Launched by OXFORD UNIVERSITY HOSPITALS NHS TRUST · Sep 5, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to using ultrasound scans to check the growth of babies during pregnancy. The goal is to better identify babies who may not be growing properly, which can lead to serious risks such as stillbirth. The trial is being conducted at Oxford University Hospitals and aims to improve the chances of detecting growth-restricted babies by following a specific care pathway. This pathway includes routine scans at 36 weeks and additional scans at 28 and 32 weeks for women based on certain risk factors. By collecting data from these scans, the researchers hope to understand how effective the pathway is in preventing complications for both mothers and babies.
To participate in the trial, women must be receiving antenatal care at Oxford University Hospitals between January 2013 and December 2019. There are no specific exclusions for this study, but women who have opted out of research related to their pregnancy or who receive care elsewhere during labor will not be eligible. Participants can expect to undergo the recommended scans and contribute to important research that could improve pregnancy care and outcomes for future mothers and babies.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • • All pregnant women receiving antenatal care at the Oxford University Hospitals NHS Foundation Trust (OUHFT) from January 2013 to 31st December 2019 with no exclusion criteria
- Exclusion Criteria:
- • Women who have opted out of research related to pregnancy in this pregnancy whilst receiving care by the OUHFT.
- • If intrapartum care takes place outside of the OUHFT.
About Oxford University Hospitals Nhs Trust
Oxford University Hospitals NHS Trust is a leading healthcare provider in the UK, renowned for its commitment to clinical excellence, research, and innovation. As a prominent academic health organization, it integrates cutting-edge medical research with patient care, facilitating a wide range of clinical trials across various therapeutic areas. The Trust collaborates closely with the University of Oxford, leveraging its world-class expertise to advance medical knowledge and improve treatment options. With a focus on patient safety and ethical standards, Oxford University Hospitals NHS Trust is dedicated to contributing to the development of new therapies and enhancing health outcomes through rigorous scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, Oxfordshire, United Kingdom
Patients applied
Trial Officials
Lawrence Impey, FRCOG
Study Director
Oxford University Hospitals NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials